New Brunswick Scientific Co., Inc. (NBSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (191)	11/10/2000 4:21:45 PM
From: scaram(o)uche	Read Replies (1) of 724

OK, after the bloodbath, what have we got? I've been saying that, projecting sales forward, we had a company that would do $50 million in sales. I've been pointing at the 40% margins. So..... today's sorry report...... sales of $12.6 million. Project that forward, and it's $50 million. Margins were 40.2%. The European patent (divisional) issued. The pIgR application is published, and the claims at the DGI site remain intact. Organica is gone. Shareholder equity, carrying some properties (my belief, please verify) at cost, is $25 million. Market cap at today's close is $35 million.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next